Study on the improvement of liver injury by controlling sinusoidal cells and spleen
控制肝窦细胞和脾脏改善肝损伤的研究
基本信息
- 批准号:12470257
- 负责人:
- 金额:$ 9.02万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1). Cold preservation and reperfusion injury of the liverApoptotic change in the liver was studied with Tunel method and electron microscopy in the cold preservation and reperfusion of the rat liver. Consequently, we found that apoptosis was occurred exclusively in the sinusoidal endothelial cells (SECs) with high incidence, leading to the detachment from the sinusoidal wall. This phenomenon was detected markedly in the cold preservation followed by reperfusion, but not in the cold preservation alone. Apoptosis in this experimental model was suppressed by vascular endothelial growth factor (VEGF) which has been well known to function as surviving and proliferative molecule. Furthermore, we showed that SEC of the fatty liver with cold storage was quite fragile and the size of the intra hepatocytic fatty droplet became larger in size as the cold preservation time was longer. These changes in the cold preserved fatty liver appeared to be one of the major causes of non-functioning graft which is frequently occurred in the fatty liver. We demonstrated that hepatocyte growth factor (HGF) ameliorated the impairment of SECs and inhibited enlargement of the fatty droplet. In addition, we showed that expressions of various kinds of the genes were changed during the cold preservation.2) Improvement of the liver cirrhosis by inhibition of activation of hepatic stellate cells. Previously, we reported that Y-27632, inhibitor of P160ROCK which is an effctor molecule of small G protein Rho, suppressed an activation of hepatic stellate cells, and that this compound inhibited the development into the liver cirrhosis in the CCL4-induced liver fibrosis of the rat. In the present study, we showed that Y-27632 ameliorated the already-established liver cirrhosis in the above-mentioned model without apparent side effects. This result may be a promising strategy for the liver cirrhosis.
1)。用TUNEL法和电镜观察了大鼠肝脏冷保存及再灌注过程中的细胞凋亡变化。因此,我们发现,细胞凋亡只发生在窦内皮细胞(SECs)的发生率很高,导致脱离窦壁。这一现象在冷保存再灌注组中明显,而在单独冷保存组中不明显。该实验模型中的细胞凋亡被血管内皮生长因子(VEGF)抑制,所述血管内皮生长因子(VEGF)已被熟知作为存活和增殖分子起作用。此外,我们发现冷藏脂肪肝的SEC相当脆弱,随着冷藏时间的延长,肝细胞内脂肪滴的尺寸变大。这些变化可能是脂肪肝中常见的移植物无功能的主要原因之一。我们证明肝细胞生长因子(HGF)可以改善SEC的损伤,抑制脂肪滴的扩大。此外,我们还发现,在冷应激过程中,各种基因的表达发生了变化。2)通过抑制肝星状细胞的活化来改善肝硬化。以前,我们报道了小G蛋白Rho的效应分子P160 ROCK的抑制剂Y-27632抑制肝星状细胞的活化,并且该化合物抑制了CCL 4诱导的大鼠肝纤维化向肝硬化的发展。在本研究中,我们表明Y-27632改善了上述模型中已经建立的肝硬化,而没有明显的副作用。这一结果可能是治疗肝硬化的一个有希望的策略。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Murata, S.Arii, et al.: "Inhibitory effect of Y-27632, a ROCK inhibitor, on pregression of rat liver fibrosis in association with inactivation of hepatic stellate cells"J. Hepatology. 35. 474-481 (2001)
T.Murata、S.Arii 等:“ROCK 抑制剂 Y-27632 对与肝星状细胞失活相关的大鼠肝纤维化进展的抑制作用”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Murata, S.Arii et al.: "Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells"J. Hepatology. 35. 474-481 (2001)
T.Murata、S.Arii 等人:“ROCK 抑制剂 Y-27632 对与肝星状细胞失活相关的大鼠肝纤维化进展的抑制作用”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arii s., Imamura M.: "Physiological role of sinusoidal endothelial cells and Kupffer cells and their inplication in the pathogenesis of liver injury"J. Hep. Bil. Panc. Surg.. 9. 40-48 (2000)
Arii s.,Imamura M.:“肝窦内皮细胞和库普弗细胞的生理作用及其在肝损伤发病机制中的意义”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Moriga, S.Arii et al.: "Protection of vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation"Transplantation. 69. 141-147 (2000)
T.Moriga、S.Arii 等:“血管内皮生长因子对冷藏引起的窦内皮损伤和细胞凋亡的保护”移植。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Arii, M.Imamura et al.: "Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury"J. Hepato-Biliary-Pancreatic Surg.. 9. 40-48 (2000)
S.Arii,M.Imamura 等:“肝窦内皮细胞和 Kupffer 细胞的生理作用及其在肝损伤发病机制中的意义”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARII Shigeki其他文献
ARII Shigeki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARII Shigeki', 18)}}的其他基金
Study on the molecular diagnosis of metastasis and recurrence and molecular targeted therapy for intractable hepato-pancreatic cancer
难治性肝胰腺癌转移复发的分子诊断及分子靶向治疗研究
- 批准号:
20249061 - 财政年份:2008
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Multidisciplinary research for molecular mechanism of cancer progression and development of diagnostic and therapeutic tool
癌症进展分子机制的多学科研究及诊断和治疗工具的开发
- 批准号:
18209043 - 财政年份:2006
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of molecular- targeting therapy and prediction of mode of recurrence by analysis of molecular mechanism of invasion and metastasis of hepatocellular carcinoma
肝细胞癌侵袭转移分子机制分析分子靶向治疗发展及复发模式预测
- 批准号:
16390375 - 财政年份:2004
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Order-made medicine for cancer in the viewpoint of angiogenesis
从血管生成的角度进行癌症定制治疗
- 批准号:
14370379 - 财政年份:2002
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel gene therapies in the field of liver surgery
肝脏外科领域新型基因疗法的开发
- 批准号:
09557104 - 财政年份:1997
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathophysiology of the liver and development of a novel therapeutics based on morphological and functional study on hepatic sinusoidal
肝脏的病理生理学以及基于肝窦形态和功能研究的新型疗法的开发
- 批准号:
08457322 - 财政年份:1996
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Implication of hepatic sinusoidal cells in pathophysiology of the liver diseases and development of novel therapeutic strategies
肝窦细胞在肝脏疾病病理生理学中的意义及新治疗策略的开发
- 批准号:
06454383 - 财政年份:1994
- 资助金额:
$ 9.02万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)